scispace - formally typeset
R

Richard C. Storr

Researcher at University of Liverpool

Publications -  149
Citations -  1896

Richard C. Storr is an academic researcher from University of Liverpool. The author has contributed to research in topics: Cycloaddition & Flash vacuum pyrolysis. The author has an hindex of 24, co-authored 149 publications receiving 1836 citations. Previous affiliations of Richard C. Storr include Liverpool School of Tropical Medicine & University of Manchester.

Papers
More filters
Journal ArticleDOI

Isoquine and Related Amodiaquine Analogues: A New Generation of Improved 4-Aminoquinoline Antimalarials

TL;DR: Isoquine (ISQ1 (3a) represents a new second generation lead worthy of further investigation as a cost-effective and potentially safer alternative to amodiaquine, and was selected for in vivo antimalarial assessment.
Journal ArticleDOI

Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.

TL;DR: The incorporation of amino functionality into target artemisinin analogues was hoped to prepare a new series of analogues that, by virtue of increased accumulation into the ferrous-rich vacuole, would display enhanced antimalarial potency.
Journal ArticleDOI

Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues.

TL;DR: A novel more efficient synthetic route to tebuquine analogues is developed which involves the use of a palladium-catalyzed Suzuki reaction to introduce the 4-chlorophenyl moiety into the4-hydroxyaniline side chain, which had the most favorable interaction energy in both the in vacuo and solvent-based simulation studies.
Journal ArticleDOI

The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine.

TL;DR: F fluorine substitution at the 2',6'-positions and replacement of the 4'-hydroxyl of amodiaquine with fluorine produces analogues that maintain antimalarial efficacy in vitro and are more resistant to oxidation and hence less likely to form toxic quinone imine metabolites in vivo.
Journal ArticleDOI

Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether

TL;DR: Ten novel, second-generation, fluorinated ether and ester analogues of the potent first-generation analogues artemether and arteether have been designed and synthesized and demonstrate high antimalarial potency in vitro against the chloroquine-sensitive HB3 and -resistant K1 strains of Plasmodium falciparum.